Local family business is runner up in the national British Small Business Awards for Exporter of the Year

Local medical device manufacturer, Bedfont Scientific Ltd., named as a runner-up for Exporter of the Year in its first-ever national business awards

Organised by SmallBusiness.co.uk and GrowthBusiness.co.uk, the British Small Business Awards was established in 2016 to commend small businesses in Britain for their quality products, services and significant contribution to Britain’s success.

Bedfont, who celebrated their 40th anniversary in 2016, a medical device manufacturer based in Harrietsham, Kent. The family company, of only 42 members, specialise in gas and breath analysis monitors for medical, scientific and industrial markets around the world. Their Medi-Gas Check range of medical pipeline testing equipment safeguards patients and staff against harmful gases, whilst their breath analysis monitors include carbon monoxide (CO) monitors such as the Smokerlyzer, for smoking cessation, and the ToxCO, to screen for CO poisoning. The NObreath FeNO monitor helps to improve asthma management, whilst the Gastrolyzer range aids in the detection of gastrointestinal disorders and food intolerances.

Bedfont named as a finalist for the Exporter of the Year accolade and although they did not receive the awards this year, the Judges highly commended Bedfont for being a British family manufacturer and for how their trade missions were working alongside smaller companies overseas and focusing on difficult markets such as Asia.

Jason Smith, Managing Director, comments, “For a small company with such a niche concept such as breath analysis to be considered for a national award is prestigious in itself. We wouldn’t be here today without our dedicated employees – the Bedfont family. Each member plays such a vital role in the success of our company and for that we are grateful. The British Small Business Awards are the first national award that Bedfont has been named as a finalist for and although we did not win this time around, we are humbled to have made it this far and will continue innovating and improving health worldwide in the hope of another chance next year.”